The therapeutic potential in the treatment of diabetes, Alzheimer’s disease, and hyperuricemia were assessed by testing its inhibitory effect on α-glucosidase, acetylcholinesterase, and xanthine oxidase. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.